Bioregulators are one of the strangest corners of peptide science — a body of research that ran for decades largely outside Western literature. Here's an even-handed introduction.

What they are

Peptide bioregulators are very short peptides — typically two, three, or four amino acids. For comparison, BPC-157 has fifteen and semaglutide is longer still. These are about as small as a peptide gets.

A two-piece peptide is a dipeptide. Three is a tripeptide. Four is a tetrapeptide. That's all those words mean.

Where they came from

Most trace to research led by Vladimir Khavinson in the Soviet Union and later Russia, beginning in the 1970s. The work was originally military-funded, and much of it was published in Russian journals — which is the main reason it's less familiar in the West.

The core idea

The proposal is that these very short peptides act as regulatory signals for specific tissues rather than as broad-acting compounds. Hence the naming convention — many are tied to a particular organ:

• Epithalon — pineal gland, studied around sleep rhythm and aging markers
• Pinealon — brain tissue
• Thymalin — thymus, studied for immune balance
• Cardiogen — heart and vessels
• Bronchogen — lungs and airways
• Prostamax — prostate
• Cartalax — cartilage and joints

Why they're intriguing

Their size. A dipeptide is small enough to raise genuinely different questions about how it moves through the body compared with larger peptides — which is part of why they keep drawing interest.

The honest caveats

This is where balance matters.

• Most research is from a single tradition. Independent replication outside Russian institutions is limited.
• Long-term human data is thin by Western regulatory standards.
• Claims often outrun evidence. Bioregulators attract sweeping longevity claims the underlying studies don't support.

None of that means the research is worthless — it means it's early and geographically concentrated. Both things can be true: an interesting body of work, and one that hasn't yet been broadly replicated.

How we describe them

In our Peptide Directory, bioregulators carry the research status "Studied mainly in Russian research." That's not a disclaimer for its own sake — it's the single most useful fact about the evidence base.

Dissolv supplies bioregulators for laboratory research only. They are not approved medicines, are not for human or veterinary consumption, and nothing here is medical advice or a claim of effectiveness.